[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarbaldehyde, 97%, 1g

1,4-Dibromo-2,3-difluorobenzene>98.0%(GC)1g

2,1,3-Benzoxadiazole, 97.0%, 5g

tert-Butyl 3-(hydroxymethyl)-1,4-diazepane-1-carboxylate hydrochloride, 98%, 250mg

Methyl 3-Hydroxyisoxazole-5-carboxylate, 97.0%, 5g

tert-Butyl benzyl(5-chloro-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate, 97%, 10g

Cyclohexanecarboxaldehyde, 97.0%, 25g

2-(6-Bromopyridin-3-yl)-1,1,1-trifluoropropan-2-ol, 98%, 5g

4-Isopropyl-2,2-dimethylbenzo[d][1,3]dioxole, 95.0%, 1g

HPTLC Plates RP-18 W / UV254 - octadecyl-modified, 5 x 20 cm, 0.25 mm, 50 Piece(s)

C-(5-p-Tolyl-[1,3,4]oxadiazol-2-yl)-methylamine; hydrochloride, 95.0%, 1g

(2-Amino-thiazol-4-yl)-acetic acid methyl ester, 97.00%, 10g

N-Glycyl-L-leucine, 95.0%, 1g